108 related articles for article (PubMed ID: 32992419)
1. [Expression of SOX-11 and TFE3 in solid-pseudopapillary tumor of pancreas and its clinical significance].
Wang Y; Fu Y; Zheng Z; Wu HY; Zhou Q; Chen KL; Tao Y; Pu XH; Ding J; Wang T; Shi J; Fan XS
Zhonghua Bing Li Xue Za Zhi; 2020 Oct; 49(10):1036-1040. PubMed ID: 32992419
[No Abstract] [Full Text] [Related]
2. Immunocytochemistry for SOX-11 and TFE3 as diagnostic markers for solid pseudopapillary neoplasms of the pancreas in FNA biopsies.
Foo WC; Harrison G; Zhang X
Cancer Cytopathol; 2017 Nov; 125(11):831-837. PubMed ID: 29045075
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of SOX11 and TFE3 in Solid-Pseudopapillary Neoplasms of the Pancreas.
Harrison G; Hemmerich A; Guy C; Perkinson K; Fleming D; McCall S; Cardona D; Zhang X
Am J Clin Pathol; 2017 Dec; 149(1):67-75. PubMed ID: 29272888
[TBL] [Abstract][Full Text] [Related]
4. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
5. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
[TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of INSM1 and SOX11 in pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm].
Cao Z; Cen HB; Zhao JH; Mei J; Qin LZ; Liao W; Ao QL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):575-581. PubMed ID: 37534634
[TBL] [Abstract][Full Text] [Related]
7. Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis.
Zhou L; Xu H; Zhou J; Dong L; Zhang P; Yang X; Wang C
Diagn Pathol; 2019 May; 14(1):34. PubMed ID: 31043173
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
[No Abstract] [Full Text] [Related]
9. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L
Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965
[TBL] [Abstract][Full Text] [Related]
10. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P
Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164
[TBL] [Abstract][Full Text] [Related]
11. [Significance of P504s in distinction between solid pseudopapillary tumor of pancreas and pancreatic neuroendocrine tumors].
Chen Z; Shi H; Ying L; Zhai X; Fu X; Liu Q; Lou S
Zhonghua Bing Li Xue Za Zhi; 2015 May; 44(5):320-2. PubMed ID: 26178213
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey.
Akgul M; Williamson SR; Ertoy D; Argani P; Gupta S; Caliò A; Reuter V; Tickoo S; Al-Ahmadie HA; Netto GJ; Hes O; Hirsch MS; Delahunt B; Mehra R; Skala S; Osunkoya AO; Harik L; Rao P; Sangoi AR; Nourieh M; Zynger DL; Smith SC; Nazeer T; Gumuskaya B; Kulac I; Khani F; Tretiakova MS; Vakar-Lopez F; Barkan G; Molinié V; Verkarre V; Rao Q; Kis L; Panizo A; Farzaneh T; Magers MJ; Sanfrancesco J; Perrino C; Gondim D; Araneta R; So JS; Ro JY; Wasco M; Hameed O; Lopez-Beltran A; Samaratunga H; Wobker SE; Melamed J; Cheng L; Idrees MT
J Clin Pathol; 2021 May; 74(5):291-299. PubMed ID: 33514585
[TBL] [Abstract][Full Text] [Related]
13. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion.
Wang XT; Xia QY; Ni H; Ye SB; Li R; Wang X; Shi SS; Zhou XJ; Rao Q
Hum Pathol; 2017 May; 63():190-200. PubMed ID: 28315422
[TBL] [Abstract][Full Text] [Related]
14. Xp11 Translocation Renal Cell Carcinomas (RCCs) With RBM10-TFE3 Gene Fusion Demonstrating Melanotic Features and Overlapping Morphology With t(6;11) RCC: Interest and Diagnostic Pitfall in Detecting a Paracentric Inversion of TFE3.
Xia QY; Wang XT; Zhan XM; Tan X; Chen H; Liu Y; Shi SS; Wang X; Wei X; Ye SB; Li R; Ma HH; Lu ZF; Zhou XJ; Rao Q
Am J Surg Pathol; 2017 May; 41(5):663-676. PubMed ID: 28288037
[TBL] [Abstract][Full Text] [Related]
15. Morphologic and Immunohistochemical Characteristics of Fluorescent In Situ Hybridization Confirmed TFE3-Gene Fusion Associated Renal Cell Carcinoma: A Single Institutional Cohort.
Akgul M; Saeed O; Levy D; Mann SA; Cheng L; Grignon DJ; Eble JN; Idrees MT
Am J Surg Pathol; 2020 Nov; 44(11):1450-1458. PubMed ID: 32701515
[TBL] [Abstract][Full Text] [Related]
16. RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH.
Argani P; Zhang L; Reuter VE; Tickoo SK; Antonescu CR
Am J Surg Pathol; 2017 May; 41(5):655-662. PubMed ID: 28296677
[TBL] [Abstract][Full Text] [Related]
17. Combination of immunohistochemistry, FISH and RT-PCR shows high incidence of Xp11 translocation RCC: comparison of three different diagnostic methods.
Lee HJ; Shin DH; Noh GY; Kim YK; Kim A; Shin N; Lee JH; Choi KU; Kim JY; Lee CH; Sol MY; Rha SH; Park SW
Oncotarget; 2017 May; 8(19):30756-30765. PubMed ID: 28415646
[TBL] [Abstract][Full Text] [Related]
18. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21).
Argani P; Antonescu CR; Couturier J; Fournet JC; Sciot R; Debiec-Rychter M; Hutchinson B; Reuter VE; Boccon-Gibod L; Timmons C; Hafez N; Ladanyi M
Am J Surg Pathol; 2002 Dec; 26(12):1553-66. PubMed ID: 12459622
[TBL] [Abstract][Full Text] [Related]
19. Utility of SOX11 for the diagnosis of solid pseudopapillary neoplasm of the pancreas on cytological preparations.
Dinarvand P; Wang WL; Roy-Chowdhuri S
Cytopathology; 2022 Mar; 33(2):216-221. PubMed ID: 34816516
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopatholigic features of renal cell carcinoma associated with chromosome X inversion harboring gene fusions involving TFE3].
Zhao YN; Wang XT; Xia QY; Wang GP; Sun SY; Zhao LF; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):574-579. PubMed ID: 30107660
[No Abstract] [Full Text] [Related]
[Next] [New Search]